医学
重症监护医学
间质性肺病
远程医疗
肺活量测定
2019年冠状病毒病(COVID-19)
疾病监测
生活质量(医疗保健)
大流行
医疗急救
远程病人监护
医疗保健
疾病
肺
病理
护理部
内科学
哮喘
经济
传染病(医学专业)
经济增长
作者
Marlies Wijsenbeek,Catharina C. Moor,Kerri A. Johannson,Peter Jackson,Yet H. Khor,Yasuhiro Kondoh,Sujeet Rajan,Gabriela Tabaj,Brenda Varela,Pieter van der Wal,Richard N. van Zyl-Smit,Michael Kreuter,Toby Maher
标识
DOI:10.1016/s2213-2600(22)00228-4
摘要
The widespread use of smartphones and the internet has enabled self-monitoring and more hybrid-care models. The COVID-19 pandemic has further accelerated remote monitoring, including in the heterogenous and often vulnerable group of patients with interstitial lung diseases (ILDs). Home monitoring in ILD has the potential to improve access to specialist care, reduce the burden on health-care systems, improve quality of life for patients, identify acute and chronic disease worsening, guide treatment decisions, and simplify clinical trials. Home spirometry has been used in ILD for several years and studies with other devices (such as pulse oximeters, activity trackers, and cough monitors) have emerged. At the same time, challenges have surfaced, including technical, analytical, and implementational issues. In this Series paper, we provide an overview of experiences with home monitoring in ILD, address the challenges and limitations for both care and research, and provide future perspectives. VIDEO ABSTRACT.
科研通智能强力驱动
Strongly Powered by AbleSci AI